NCT04715425View on ClinicalTrials.gov

Thoracoscopic Surgical Versus Catheter Ablation Approaches for Primary Treatment of Persistent Atrial Fibrillation

NARecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

September 25, 2019

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2028

Conditions
Atrial Fibrillation, Persistent
Interventions
PROCEDURE

Thoracoscopic pulmonary vein isolation without additional lesion + left atrial appendage exclusion/amputation

Bilateral pulmonary vein isolation using radiofrequency energy

PROCEDURE

Catheter pulmonary vein isolation without additional lesions

Bilateral pulmonary vein isolation using radiofrequency energy

Trial Locations (3)

Unknown

RECRUITING

Amsterdam University Medical Center location AMC, Amsterdam

NOT_YET_RECRUITING

Maastricht UMC+, Maastricht

RECRUITING

St. Antonius Ziekenhuis Nieuwegein, Nieuwegein

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER